Published in Blood Weekly, July 12th, 2001
Catherine Leport and colleagues at the Xavier Bichat Faculty of Medicine in France and other institutions conducted a study comparing different prognostic indicators of high TE risk. Their results were published in the journal Clinical and Diagnostic Laboratory Immunology.
Immunoblot testing provided the most reliable marker of elevated TE...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.